Squarepoint
MBOT icon

Squarepoint’s Microbot Medical MBOT Stock Holding History

Squarepoint’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6K Sell
20,286
-105,307
-84% -$215K ﹤0.01% 4280
2026
Q1 		$303K Buy
125,593
+101,067
+412% +$226K ﹤0.01% 3697
2025
Q4 		$49.1K Buy
24,526
+12,419
+103% +$29.4K ﹤0.01% 4132
2025
Q3 		$36.9K Buy
+12,107
New +$37.8K ﹤0.01% 4253
2025
Q2 		– Sell
-14,616
Closed -$22.1K – 4827
2025
Q1 		$22.1K Buy
+14,616
New +$25.8K ﹤0.01% 4430
2017
Q4 		– Sell
-2,593
Closed -$46K – 2239
2017
Q3 		$46K Buy
+2,593
New +$45.7K ﹤0.01% 1567

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Squarepoint's MBOT Position: Q2 2026 in Review

Squarepoint reduced its Microbot Medical (MBOT) stake by 84% in Q2 2026, selling an estimated $215K and leaving 20,286 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4280.

Squarepoint first reported a position in MBOT in Q3 2017 and has held it in 6 quarters since. The position peaked at $303K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Squarepoint held 20,286 shares of Microbot Medical worth $39.6K as of Q2 2026.
  • Squarepoint sold 105,307 Microbot Medical shares in Q2 2026, an estimated $215K.
  • Microbot Medical made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4280 holding.
  • Squarepoint first reported a position in Microbot Medical in Q3 2017 and has held it in 6 quarters since.
  • Squarepoint's Microbot Medical position peaked at $303K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.